Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

The PRESERVE Trial is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States.

It is sponsored by IVC Filter Study Group Foundation, which is a joint collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).

Learn More

The Latest from PRESERVE

NEWS

PRESERVE presented by Matthew Johnson, MD on 02/Oct/2015 at MDEpiNet at FDA White Oak Campus, Silver Spring, MD as an innovative coordinated registry network (CRN).

NEWS

As of October 6, 2015, PRESERVE has been launched and is open for enrollment.

FOR PATIENTS

If you are considering participating or already enrolled in PRESERVE »

Important information about PRESERVE.